{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:57:03Z","timestamp":1790164623537,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009131","name":"Direktion f\u00fcr Entwicklung und Zusammenarbeit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","award":["AN4169\/EPL-BS497"],"award-info":[{"award-number":["AN4169\/EPL-BS497"]}],"id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","award":["EPL-BS1246"],"award-info":[{"award-number":["EPL-BS1246"]}],"id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","award":["EPL-BS967"],"award-info":[{"award-number":["EPL-BS967"]}],"id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000278","name":"Department for International Development, UK Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2007-00559"],"award-info":[{"award-number":["2007-00559"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003708","name":"Korea Institute of Science and Technology Information","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008196","name":"M\u00e9decins Sans Fronti\u00e8res","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ijpddr.2020.06.001","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T02:24:26Z","timestamp":1592015066000},"page":"107-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity"],"prefix":"10.1016","volume":"13","author":[{"given":"Caio H.","family":"Franco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Warhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2341-2898","authenticated-orcid":false,"given":"Ho Y.A.","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6510-2409","authenticated-orcid":false,"given":"Miriam A.","family":"Giardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno S.","family":"Pascoalino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Claudia","family":"Torrecilhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia M.D.","family":"Romera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7319-2929","authenticated-orcid":false,"given":"Rafael Pedro","family":"Madeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9353-8480","authenticated-orcid":false,"given":"Sergio","family":"Schenkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio H.","family":"Freitas-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Chatelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina B.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2020.06.001_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2017.05.001","article-title":"Chagas disease in Europe: a review for the internist in the globalized world","volume":"43","author":"Antinori","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.mi.49.100195.002235","article-title":"New mechanisms of drug resistance in parasitic protozoa","volume":"49","author":"Borst","year":"1995","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.molbiopara.2003.07.004","article-title":"Cloning and analysis of Trypanosoma cruzi lanosterol 14\u03b1-demethylase","volume":"132","author":"Buckner","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib4","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1128\/AAC.42.12.3245","article-title":"Induction of resistance to azole drugs in Trypanosoma cruzi","volume":"42","author":"Buckner","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib5","first-page":"93","article-title":"Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media","author":"Camargo","year":"1964","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.ijpddr.2020.06.001_bib6","doi-asserted-by":"crossref","first-page":"14407","DOI":"10.1038\/s41598-017-14986-6","article-title":"Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole","volume":"7","author":"Campos","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molbiopara.2014.01.002","article-title":"Benznidazole-resistance in Trypanosoma cruzi: evidence that distinct mechanisms can act in concert","volume":"193","author":"Campos","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib8","doi-asserted-by":"crossref","first-page":"e1216","DOI":"10.1371\/journal.pntd.0001216","article-title":"Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome","volume":"5","author":"Cencig","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib9","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3389\/fmicb.2019.03127","article-title":"Uncovering new mutations conferring azole resistance in the Aspergillus fumigatus cyp51A gene","volume":"10","author":"Chen","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib10","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.febslet.2014.08.030","article-title":"Sequence variation in CYP51A from the Y strain of Trypanosoma cruzi alters its sensitivity to inhibition","volume":"588","author":"Cherkesova","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4269\/ajtmh.16-0975","article-title":"Lack of efficacy of liposomal amphotericin B against acute and chronic Trypanosoma cruzi infection in mice","volume":"97","author":"Clemons","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1128\/MMBR.00024-10","article-title":"Cell biology of the trypanosome genome","volume":"74","author":"Daniels","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib13","first-page":"1219","article-title":"Differential effect of amphotericin B on the three evolutive stages of Trypanosoma cruzi and on the host cell-parasite interaction","volume":"26","author":"De-Castro","year":"1993","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20011433","article-title":"A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage","volume":"195","author":"Di Noia","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.1112631","article-title":"The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease","volume":"309","author":"El-Sayed","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2020.06.001_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease","volume":"81","author":"Filardi","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib17","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1128\/AAC.00520-15","article-title":"Limited ability of posaconazole to cure both acute and chronic Trypanosoma cruzi infections revealed by highly sensitive in vivo imaging","volume":"59","author":"Francisco","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib18","first-page":"82","article-title":"Drug discovery for Chagas disease: impact of different host cell lines on assay performance and hit compound selection","volume":"4","author":"Franco","year":"2019","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib19","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1371\/journal.pntd.0000984","article-title":"Shotgun sequencing analysis of Trypanosoma cruzi I Sylvio X10\/1 and comparison with T. cruzi VI CL Brener","volume":"5","author":"Franz\u00e9n","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0166-6851(89)90069-8","article-title":"The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitro","volume":"32","author":"Goad","year":"1989","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0021-9258(18)48462-1","article-title":"Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences","volume":"267","author":"Gotoh","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.01114-13","article-title":"Trypanosoma cruzi clone Dm28c draft genome sequence","volume":"2","author":"Grisard","year":"2014","journal-title":"Genome Announc."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jac\/dks478","article-title":"Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection","volume":"68","author":"Gulin","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0009-2797(89)90092-6","article-title":"Amphotericin B-induced damage of Trypanosoma cruzi epimastigotes","volume":"71","author":"Haido","year":"1989","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib25","first-page":"95","article-title":"BioEdit: a user friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT","volume":"41","author":"Hall","year":"1999","journal-title":"Nucleic Acids Symp. Ser."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib26","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1074\/jbc.M117.778308","article-title":"Structural analyses of Candida albicans sterol 14\u03b1-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis","volume":"292","author":"Hargrove","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib27","doi-asserted-by":"crossref","first-page":"31602","DOI":"10.1074\/jbc.M113.497990","article-title":"Complexes of Trypanosoma cruzi sterol 14\u03b1-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity","volume":"288","author":"Hargrove","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s13059-014-0511-2","article-title":"A genomic and evolutionary approach reveals non-genetic drug resistance in malaria","volume":"15","author":"Herman","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib29","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1021\/jm2015809","article-title":"Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease","volume":"55","author":"Keenan","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib30","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1128\/AAC.00689-15","article-title":"Antitrypanosomal treatment with benznidazole is superior to posaconazole regimens in mouse models of Chagas disease","volume":"59","author":"Khare","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/bip.20417","article-title":"Determination of intrinsic hydrophilicity\/hydrophobicity of amino acid side chains in peptides in the absence of nearest-neighbor or conformational effects","volume":"84","author":"Kovacs","year":"2006","journal-title":"Biopolymers"},{"key":"10.1016\/j.ijpddr.2020.06.001_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","article-title":"Global economic burden of Chagas disease: a computational simulation model","volume":"13","author":"Lee","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib33","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1074\/jbc.M109.067470","article-title":"Crystal structures of Trypanosoma brucei sterol 14\u03b1-demethylase and implications for selective treatment of human infections","volume":"285","author":"Lepesheva","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib34","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2174\/156802611796575902","article-title":"Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis","volume":"11","author":"Lepesheva","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbagen.2006.07.018","article-title":"Sterol 14\u03b1-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms","volume":"1770","author":"Lepesheva","year":"2007","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib36","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1074\/jbc.M510317200","article-title":"CYP51 from Trypanosoma cruzi: a phyla-specific residue in the B\u2019 helix defines substrate preferences of sterol 14\u03b1-demethylase","volume":"281","author":"Lepesheva","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib37","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4269\/ajtmh.2009.09-0305","article-title":"Genotyping of Trypanosoma cruzi: systematic selection of assays allowing rapid and accurate discrimination of all known lineages","volume":"81","author":"Lewis","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4269\/ajtmh.1986.35.280","article-title":"In vitro and in vivo effects of itraconazole against Trypanosoma cruzi","volume":"35","author":"McCabe","year":"1986","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib39","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas' disease","volume":"370","author":"Molina","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1517\/17460441.2016.1160883","article-title":"Novel drug discovery for Chagas disease","volume":"11","author":"Moraes","year":"2016","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib41","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1038\/srep04703","article-title":"Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development","volume":"4","author":"Moraes","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib42","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of benznidazole for chronic Chagas' cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib43","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and posaconazole in eliminating parasites in asymptomatic T. cruzi carriers: the STOP-CHAGAS trial","volume":"69","author":"Morillo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpddr.2016.08.004","article-title":"Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V","volume":"6","author":"Oguike","year":"2016","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejmech.2017.12.011","article-title":"Investigating the structure-activity relationships of N\u2019 -[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds","volume":"144","author":"Palace-Berl","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib46","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/jac\/dkp357","article-title":"Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis","volume":"64","author":"P\u00e9rez-Molina","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2020.06.001_bib48","doi-asserted-by":"crossref","first-page":"W314","DOI":"10.1093\/nar\/gku411","article-title":"DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach","volume":"42","author":"Pires","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib49","series-title":"Lipids of Pathogenic Fungii","author":"Prasad","year":"1996"},{"key":"10.1016\/j.ijpddr.2020.06.001_bib50","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"56","author":"Purkait","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib51","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1101\/gad.14.12.1471","article-title":"FACKEL is a sterol C-14 reductase required for organized cell division and expansion in Arabidopsis embryogenesis","volume":"14","author":"Schrick","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-5320(83)90064-3","article-title":"Reorganization of membrane ergosterol during cell fission events of Candida albicans: a freeze-fracture study of distribution of filipin-ergosterol complexes","volume":"83","author":"Sekiya","year":"1983","journal-title":"J. Ultrasruct. Res."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib53","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ejmech.2016.04.065","article-title":"Design, synthesis and antitrypanosomal activity of some nitrofurazone 1,2,4-triazolic bioisosteric analogues","volume":"121","author":"Silva","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib54","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1128\/AAC.00070-13","article-title":"In vitro and in vivo studies of the antiparasitic activity of sterol 14\u03b1-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi","volume":"57","author":"Soeiro","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib55","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jmb.2010.01.075","article-title":"Structural basis of human CYP51 inhibition by antifungal azoles","volume":"397","author":"Strushkevich","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","volume":"115","author":"Urbina","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib57","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0924-8579(02)00273-X","article-title":"In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease","volume":"21","author":"Urbina","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpddr.2020.06.001_bib58","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of benznidazole for chronic Chagas' cardiomyopathy","volume":"373","author":"Velazquez","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib59","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial","volume":"144","author":"Viotti","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02586-18","article-title":"The evolution of azole resistance in Candida albicans sterol 14\u03b1-demethylase (CYP51) through incremental amino acid substitutions","volume":"63","author":"Warrilow","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib61","series-title":"Sustaining the Drive to Overcome the Global Impact of Neglected Tropical Diseases, Second WHO Report on Neglected Tropical Diseases","author":"WHO","year":"2013"},{"key":"10.1016\/j.ijpddr.2020.06.001_bib62","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1073\/pnas.0711014105","article-title":"A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes","volume":"105","author":"Wilkinson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib63","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4269\/ajtmh.1999.61.193","article-title":"In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections","volume":"61","author":"Yardley","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib64","series-title":"DNA Submission Guidance for PacBio SMRT Sequencing","author":"Yuan","year":"2012"},{"key":"10.1016\/j.ijpddr.2020.06.001_bib65","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1371\/journal.pntd.0000488","article-title":"Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of M\u00e9decins Sans Fronti\u00e8res","volume":"3","author":"Yun","year":"2009","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib66","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3389\/fmicb.2019.00691","article-title":"The fungal CYP51s: their functions, structures, related drug resistance, and inhibitors","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.06.001_bib67","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1590\/0074-02760140407","article-title":"A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole","volume":"110","author":"Zingales","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:50:24Z","timestamp":1761922224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320720300142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":67,"alternative-id":["S2211320720300142"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.06.001","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}